Measure O – Citizens' Oversight Committee
Meetings: Committee will be active from January through August each year with a minimum of two meetings anticipated annually.
Meeting Location: Community Meeting Center
11300 Stanford Avenue
Garden Grove, CA 92840
The purpose of the Measure O Citizens’ Oversight Committee is to provide citizen oversight of Measure O funds to ensure all funds are properly spent. The Measure O Citizens’ Oversight Committee reviews the City’s annual general fund budget, mid-year budget, and yearend audited financial information in regards to the receipt and expenditure of the fiscal year’s one-cent transactions and use (sales) tax revenue. This review is based on the City’s Measure O Ordinance No. 2897 adopted by the voters, and input received via the Community Priorities Survey. The committee communicates its findings to the public and the City Council annually (GGMC 3.09.160) and City Council Resolution No. 9540-19).
Commissioner |
Appointed to Commission |
Current Term Expires |
---|---|---|
Kris Beard |
03/14/23 |
12/2024 |
Claire Bischoff |
03/14/23 |
12/2024 |
Fernando Ferrer |
03/14/23 |
12/2024 |
Mark Mackanic |
03/14/23 |
12/2024 |
Les Malo |
03/14/23 |
12/2024 |
Robert Sanders |
03/14/23 |
12/2024 |
Sandy Thomas |
03/14/23 |
12/2024 |
Patricia Song
Finance Department
Director
11222 Acacia Parkway
Garden Grove, CA 92840
Office: (714) 741-5062
E-mail: psong@ggcity.org
Alvaro Castellon
Finance Department
Finance Manager
11222 Acacia Parkway
Garden Grove, CA 92840
Office: (714) 741-5058
E-mail: alvaroc@ggcity.org
Members of the public are asked to consider very carefully before attending this meeting in person and are required to wear face masks and maintain a six-foot distance from others. Please do not attend this meeting if you have traveled and/or have had direct contact with someone who has travelled to places experiencing high rates of infection or tested positive for COVID-19, or if you are experiencing symptoms such as coughing, sneezing, fever, difficulty breathing or other flu-like symptoms.